Cargando…
A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476015/ https://www.ncbi.nlm.nih.gov/pubmed/25978434 http://dx.doi.org/10.1038/bcj.2015.36 |
| _version_ | 1782377534937104384 |
|---|---|
| author | Nagao, T Oshikawa, G Ishida, S Akiyama, H Umezawa, Y Nogami, A Kurosu, T Miura, O |
| author_facet | Nagao, T Oshikawa, G Ishida, S Akiyama, H Umezawa, Y Nogami, A Kurosu, T Miura, O |
| author_sort | Nagao, T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4476015 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44760152015-06-30 A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival Nagao, T Oshikawa, G Ishida, S Akiyama, H Umezawa, Y Nogami, A Kurosu, T Miura, O Blood Cancer J Letter to the Editor Nature Publishing Group 2015-05 2015-05-15 /pmc/articles/PMC4476015/ /pubmed/25978434 http://dx.doi.org/10.1038/bcj.2015.36 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Nagao, T Oshikawa, G Ishida, S Akiyama, H Umezawa, Y Nogami, A Kurosu, T Miura, O A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival |
| title | A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival |
| title_full | A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival |
| title_fullStr | A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival |
| title_full_unstemmed | A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival |
| title_short | A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival |
| title_sort | novel myd88 mutation, l265rpp, in waldenström macroglobulinemia activates the nf-κb pathway to upregulate bcl-xl expression and enhances cell survival |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476015/ https://www.ncbi.nlm.nih.gov/pubmed/25978434 http://dx.doi.org/10.1038/bcj.2015.36 |
| work_keys_str_mv | AT nagaot anovelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT oshikawag anovelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT ishidas anovelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT akiyamah anovelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT umezaway anovelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT nogamia anovelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT kurosut anovelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT miurao anovelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT nagaot novelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT oshikawag novelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT ishidas novelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT akiyamah novelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT umezaway novelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT nogamia novelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT kurosut novelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival AT miurao novelmyd88mutationl265rppinwaldenstrommacroglobulinemiaactivatesthenfkbpathwaytoupregulatebclxlexpressionandenhancescellsurvival |